Early DAS response after DMARD-start increases probability of achieving sustained DMARD-free remission in rheumatoid arthritis.

Marloes VerstappenE NiemantsverdrietX M E MatthijssenS le CessieA H M van der Helm-van Mil

Published in: Arthritis research & therapy (2020)

In ACPA-negative RA, an early response to treatment, i.e., a strong DAS decline within the first 4 months, is associated with a higher probability of SDFR development. DAS values at 4 months could be useful for later decisions to stop DMARDs.

Keyphrases

disease activity
rheumatoid arthritis
rheumatoid arthritis patients
systemic lupus erythematosus
ankylosing spondylitis
interstitial lung disease
systemic sclerosis
replacement therapy